ATE230601T1 - Dexamethason-gel - Google Patents

Dexamethason-gel

Info

Publication number
ATE230601T1
ATE230601T1 AT98954349T AT98954349T ATE230601T1 AT E230601 T1 ATE230601 T1 AT E230601T1 AT 98954349 T AT98954349 T AT 98954349T AT 98954349 T AT98954349 T AT 98954349T AT E230601 T1 ATE230601 T1 AT E230601T1
Authority
AT
Austria
Prior art keywords
dexamethason
gel
dexamethason gel
Prior art date
Application number
AT98954349T
Other languages
German (de)
English (en)
Inventor
Guenther Bellmann
Gudrun Claus-Herz
Christoph Kessler
Original Assignee
Mann Gerhard Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mann Gerhard Chem Pharm Fab filed Critical Mann Gerhard Chem Pharm Fab
Application granted granted Critical
Publication of ATE230601T1 publication Critical patent/ATE230601T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AT98954349T 1997-10-06 1998-10-05 Dexamethason-gel ATE230601T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19744113A DE19744113A1 (de) 1997-10-06 1997-10-06 Dexamethason-Gel
PCT/EP1998/006339 WO1999017780A1 (de) 1997-10-06 1998-10-05 Dexamethason-gel

Publications (1)

Publication Number Publication Date
ATE230601T1 true ATE230601T1 (de) 2003-01-15

Family

ID=7844743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98954349T ATE230601T1 (de) 1997-10-06 1998-10-05 Dexamethason-gel

Country Status (18)

Country Link
EP (1) EP1021192B1 (pt)
JP (1) JP4156793B2 (pt)
KR (1) KR100392481B1 (pt)
CN (1) CN1142782C (pt)
AR (1) AR017170A1 (pt)
AT (1) ATE230601T1 (pt)
BR (1) BR9812849A (pt)
CA (1) CA2300806C (pt)
DE (2) DE19744113A1 (pt)
DK (1) DK1021192T3 (pt)
ES (1) ES2191352T3 (pt)
HK (1) HK1030748A1 (pt)
HU (1) HU224986B1 (pt)
IL (1) IL135001A0 (pt)
MX (1) MXPA00003363A (pt)
PL (1) PL189727B1 (pt)
WO (1) WO1999017780A1 (pt)
ZA (1) ZA989066B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808375A (en) 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
CN101190177B (zh) * 2006-11-24 2010-09-01 上海医药工业研究院 醋酸地塞米松局部成膜凝胶组合物及其应用
US20150190407A1 (en) * 2014-01-07 2015-07-09 Insite Vision Incorporated Methods for treatment of postoperative inflammation with reduced intraocular pressure

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2212392C3 (de) * 1972-03-15 1981-03-19 Avicon Inc., Fort Worth, Tex. Verwendung von mikrokristallinem Collagen zur Herstellung eines wäßrigen pharmazeutischen Mittels für die topische Anwendung am Auge
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
EP0028110B1 (en) * 1979-10-26 1984-03-07 Smith and Nephew Associated Companies p.l.c. Autoclavable emulsions
JPS63174924A (ja) * 1987-01-14 1988-07-19 Toko Yakuhin Kogyo Kk 軟膏基剤および軟膏剤
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
AU5084693A (en) * 1993-08-20 1995-03-21 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
DE4404990C1 (de) * 1994-02-17 1995-05-04 Mann Gerhard Chem Pharm Fab Verfahren zur Herstellung eines sterilen Prednisolongels
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Also Published As

Publication number Publication date
PL341026A1 (en) 2001-03-26
DE59806884D1 (en) 2003-02-13
ES2191352T3 (es) 2003-09-01
WO1999017780A1 (de) 1999-04-15
CA2300806C (en) 2004-02-03
JP4156793B2 (ja) 2008-09-24
HU224986B1 (en) 2006-05-29
DK1021192T3 (da) 2003-05-05
KR20010030939A (ko) 2001-04-16
CN1142782C (zh) 2004-03-24
ZA989066B (en) 1999-06-15
DE19744113A1 (de) 1999-04-15
EP1021192B1 (de) 2003-01-08
HK1030748A1 (en) 2001-05-18
CA2300806A1 (en) 1999-04-15
WO1999017780A8 (de) 2000-01-27
CN1266369A (zh) 2000-09-13
JP2001518510A (ja) 2001-10-16
HUP0003796A3 (en) 2001-05-28
MXPA00003363A (es) 2007-12-07
HUP0003796A2 (hu) 2001-04-28
BR9812849A (pt) 2000-08-08
IL135001A0 (en) 2001-05-20
EP1021192A1 (de) 2000-07-26
KR100392481B1 (ko) 2003-07-23
PL189727B1 (pl) 2005-09-30
AR017170A1 (es) 2001-08-22

Similar Documents

Publication Publication Date Title
DE69717181D1 (de) Entwicklungseinheit
ATE208395T1 (de) Thiophenopyrimidine
DE69722695D1 (de) Fluoroelastomerteile
ATE262512T1 (de) Arylalkanoylpyridazine
DE59706453D1 (de) 3-amino-1-cyanophenyl-uracile
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
DE59710831D1 (de) Brennstoffvorverdampfer
BR9703563A (pt) Hidromancal
BR9703835A (pt) Hidromancal
ID22673A (id) Pululanase jagung
NO991261D0 (no) Sinksulfidpigment
NO992262L (no) F¾rsupplement
FI961179A0 (fi) Stroemuttagsanordning foer en kontaktskena
DE69812129D1 (de) Gelmaterialien
ATE230601T1 (de) Dexamethason-gel
DE69739606D1 (de) Ichten verbindungsstellen
FI971344A0 (fi) En vattenavlaegsningsanordning foer en former
ID17224A (id) Sediaan
KR970004345U (ko) 스티커식 바둑
NO303519B1 (no) Sterkstr°m-installasjonsenhet
SE9602173D0 (sv) Representationskort
ATE267568T1 (de) Epithese
BR7600260U (pt) Multi-morsa
BR9606252A (pt) Cromosauna
BR7601548U (pt) Tomadamax